MS&AD Insurance Group Holdings, Inc.

DB:59M Stock Report

Market Cap: €32.8b

MS&AD Insurance Group Holdings Valuation

Is 59M undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 59M when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 59M (€20.8) is trading below our estimate of fair value (€58.69)

Significantly Below Fair Value: 59M is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 59M?

Key metric: As 59M is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 59M. This is calculated by dividing 59M's market cap by their current earnings.
What is 59M's PE Ratio?
PE Ratio7.1x
EarningsJP¥740.74b
Market CapJP¥5.26t

Price to Earnings Ratio vs Peers

How does 59M's PE Ratio compare to its peers?

The above table shows the PE ratio for 59M vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11.8x
HNR1 Hannover Rück
13.3x5.7%€29.8b
TLX Talanx
10.8x5.0%€20.5b
MUV2 Münchener Rückversicherungs-Gesellschaft in München
11.4x2.9%€64.9b
ALV Allianz
11.8x5.9%€112.0b
59M MS&AD Insurance Group Holdings
7.1x-0.9%€5.3t

Price-To-Earnings vs Peers: 59M is good value based on its Price-To-Earnings Ratio (7.1x) compared to the peer average (11.8x).


Price to Earnings Ratio vs Industry

How does 59M's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
59M 7.1xIndustry Avg. 12.1xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 59M is good value based on its Price-To-Earnings Ratio (7.1x) compared to the European Insurance industry average (11.9x).


Price to Earnings Ratio vs Fair Ratio

What is 59M's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

59M PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio7.1x
Fair PE Ratio7.2x

Price-To-Earnings vs Fair Ratio: 59M is good value based on its Price-To-Earnings Ratio (7.1x) compared to the estimated Fair Price-To-Earnings Ratio (7.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 59M forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€20.80
€23.33
+12.2%
15.7%€31.18€19.21n/a12
Nov ’25€20.40
€22.98
+12.7%
15.7%€30.72€18.92n/a12
Oct ’25€20.60
€23.72
+15.2%
15.5%€31.60€19.47n/a12
Sep ’25€20.60
€21.63
+5.0%
21.3%€29.95€11.98n/a11
Aug ’25€20.40
€21.63
+6.0%
21.3%€29.95€11.98n/a11
Jul ’25€21.20
€19.32
-8.9%
26.3%€29.50€11.80n/a11
Jun ’25€19.00
€16.12
-15.2%
20.6%€23.45€11.72n/a11
May ’25€16.30
€15.69
-3.7%
17.1%€20.72€11.84n/a11
Apr ’25€17.00
€15.68
-7.7%
17.7%€20.61€11.84n/a12
Mar ’25€15.60
€12.96
-16.9%
11.8%€15.77€10.80n/a11
Feb ’25€12.60
€12.43
-1.3%
11.0%€15.43€10.43n/a11
Jan ’25€11.73
€12.65
+7.8%
9.8%€15.48€10.60n/a12
Dec ’24€11.47
€12.13
+5.8%
10.2%€15.06€10.31n/a13
Nov ’24€11.73
€12.25
+4.4%
12.0%€15.35€9.88€20.4013
Oct ’24€11.53
€12.03
+4.3%
12.8%€15.44€9.94€20.6012
Sep ’24€11.00
€11.91
+8.3%
13.2%€15.44€9.94€20.6012
Aug ’24€11.07
€12.05
+8.9%
14.7%€15.75€10.14€20.4011
Jul ’24€10.60
€11.43
+7.9%
11.4%€13.76€9.95€21.2011
Jun ’24€10.60
€10.83
+2.2%
11.1%€12.94€9.00€19.0010
May ’24€9.67
€10.99
+13.7%
10.2%€12.65€9.17€16.3012
Apr ’24€9.27
€11.41
+23.2%
11.1%€13.17€9.55€17.0010
Mar ’24€10.13
€10.83
+6.9%
9.3%€12.13€9.22€15.6010
Feb ’24€9.73
€10.96
+12.6%
8.9%€12.39€9.42€12.6011
Jan ’24€9.80
€11.10
+13.3%
8.5%€12.58€9.49€11.7313
Dec ’23€9.20
€11.03
+19.9%
8.0%€12.40€9.55€11.4713
Nov ’23€8.80
€10.67
+21.3%
7.7%€12.07€9.29€11.7313

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies